FENC 8-K 2026-09-17

FENNEC PHARMACEUTICALS INC. (FENC) 8-K dated 2026-09-17 — accession 0001104659-26-108565. This URL is the filing, not the FENC hub.

FENNEC PHARMACEUTICALS INC. (FENC) is a biotechnology company listed on US.

FENNEC PHARMACEUTICALS INC. filed a 8-K on 2026-09-17. Accession 0001104659-26-108565.

Cached items: 8.01, 9.01. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported FENC revenue for 2025-12-31 was $44.6M. Net income was -$9.7M. Revenue was down 6.1% from 2024-12-31 to 2025-12-31. FENC currently screens at market cap $302.2M.

Not investment advice. The FENC SEC hub lists recent forms. The stock page is the research view.